• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Virtual colonoscopy tops conventional screening

Article

The removal of lesions 6 mm or greater found by CT colonography screening is more cost-effective, safer, and just as clinically effective as colonoscopy or flexible sigmoidoscopy, according to a study in the June 1 issue of Cancer.

The removal of lesions 6 mm or greater found by CT colonography screening is more cost-effective, safer, and just as clinically effective as colonoscopy or flexible sigmoidoscopy, according to a study in the June 1 issue of Cancer.

Dr. Perry Pickhardt, an associate professor of radiology at the University of Wisconsin, and Dr. Cesare Hassan, a gastroenterologist in Rome, collaborated on the analysis. Their findings contradict previous ones showing that colonoscopy and flexible sigmoidoscopy of all sizes of polyps are more cost-effective than CT colonography. Earlier studies, however, ignored CT colonography guidelines on reporting only polyps greater than 5 mm. The cost per life-year gained from CT screening with a 6-mm threshold for follow-up was $4361 compared with $9180 for colonoscopy. The cost per life-year gained with CT screening with no polyp size threshold was $7138, compared with $7407 for flexible sigmoidoscopy.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.